Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cancer treatment methods based on TP53 mutation status and hypermutation

Cancer treatment methods based on TP53 mutation status and hypermutation

US Patent 12048699 · Granted Jul 30, 2024

Estimated economic value: $124,260,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for data copy offload for storage devices2024
Antibodies specific for DR5 and methods of use2022
Method of predicting effects of CDC7 inhibitor2021
Method of predicting effects of CDC7 inhibitor2021
Method of predicting effects of CDC7 inhibitor2021
Biomarkers and methods to predict response to inhibitors and uses thereof2020
Memory system and controlling method2020
Memory system and controlling method2018
Bispecific antibodies specific for FAP and DR5, antibodies specific for DR52018
Biomarkers of response to proteasome inhibitors2018
Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora 2017
Cell penetrating peptides to target EIF4E2016